These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2246832

  • 1. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case].
    Uemura Y, Iwahara Y, Kataoka R, Muneishi H, Miyoshi I.
    Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK.
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [Abstract] [Full Text] [Related]

  • 8. [Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
    Tanosaki R, Uchida H, Masuda Y, Michikawa N, Ogawa T, Kubo A, Ikeda Y.
    Rinsho Ketsueki; 1992 Feb; 33(2):256-8. PubMed ID: 1635179
    [Abstract] [Full Text] [Related]

  • 9. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ, Elfenbein GJ, Braylan RC, Jones J, Weiner RS.
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [Abstract] [Full Text] [Related]

  • 10. Childhood idiopathic myelofibrosis: a case report and review of literature.
    Noor-Fadzilah Z, Leong CF, Sabariah MN, Cheong SK.
    Malays J Pathol; 2009 Dec; 31(2):129-32. PubMed ID: 20514856
    [Abstract] [Full Text] [Related]

  • 11. Effect of alkylating agents on hematopoiesis in myelofibrosis. 4 case report.
    Charbord P, Neel H, Caillou B, Kahn E, Parmentier C.
    Nouv Rev Fr Hematol (1978); 1984 Dec; 26(6):361-9. PubMed ID: 6527942
    [Abstract] [Full Text] [Related]

  • 12. [Idiopathic myelofibrosis transformed to acute myelomonocytic leukemia associated with non-Hodgkin's lymphoma].
    Kato M, Umeda M, Kosuge T, Anno S, Tsukahara T, Shirai T.
    Rinsho Ketsueki; 1994 Jun; 35(6):581-7. PubMed ID: 8078193
    [Abstract] [Full Text] [Related]

  • 13. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V.
    Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
    [Abstract] [Full Text] [Related]

  • 14. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A, Lottenberg R, Griffith R, Reinhard E.
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.
    Paquette RL, Meshkinpour A, Rosen PJ.
    Medicine (Baltimore); 1994 May; 73(3):145-52. PubMed ID: 8190037
    [Abstract] [Full Text] [Related]

  • 16. [Idiopathic myelofibrosis].
    Saad GM, de Almeida TV.
    Rev Paul Med; 1991 May; 109(2):47-50. PubMed ID: 1887177
    [Abstract] [Full Text] [Related]

  • 17. [Neutrophilic myelofibrosis; a case report].
    Okamoto R, Harano H, Tamura T, Tanabe J, Fujita H, Fukawa H, Kanamori H, Matsuźaki M, Motomura S, Mohri H.
    Rinsho Ketsueki; 1993 Aug; 34(8):957-61. PubMed ID: 8411651
    [Abstract] [Full Text] [Related]

  • 18. [Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome].
    Hattori N, Nakashima H, Usui T, Maeda T, Yanagisawa K, Nakamaki T, Tomoyasu S.
    Rinsho Ketsueki; 2007 Dec; 48(12):1539-43. PubMed ID: 18203513
    [Abstract] [Full Text] [Related]

  • 19. Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis--an entity different from adults.
    DeLario MR, Sheehan AM, Ataya R, Bertuch AA, Vega C, Webb CR, Lopez-Terrada D, Venkateswaran L.
    Am J Hematol; 2012 May; 87(5):461-4. PubMed ID: 22389089
    [Abstract] [Full Text] [Related]

  • 20. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM, Hernández Nieto L, Brito Barroso ML, Hernández García MT.
    Med Clin (Barc); 1994 Mar 19; 102(10):380-2. PubMed ID: 8182985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.